US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voya Infrastructure Industrials and Materials Fund

9.49

-0.7300-7.14%

Post-market: 9.41-0.0800-0.84%16:05 EDT

Volume:171.74K

Turnover:1.68M

Market Cap:182.96M

PE:- -

High:10.11

Open:10.11

Low:9.45

Close:10.22

Loading ...

Overview Company News Filings

Data Vault Holdings, Inc.® Receives Foundational Web 3.0 Data, Blockchain and Artificial Intelligence Patents

A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter

Data Vault Holdings Unveils DVHolo: A Next-Generation Hologram Product Suite Powered by ADIO® in Partnership with HYPERVSN

Press Release: WiSA Technologies Announces Upcoming Investor Conferences

Press Release: Voya Equity Closed End Funds Declare Distributions

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

FDA Grants iota Biosciences IDE Approval for First-In-Human Early Feasibility Study with Implantable Bladder Device

InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

BRIEF-InspireMD Announces Approval Of Application For Pivotal Study Of The CGuard Prime 80Cm Carotid Stent System

InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IDE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","market":"US","secType":"STK","nameCN":"Voya Infrastructure Industrials and Materials Fund","latestPrice":9.49,"timestamp":1743796800000,"preClose":10.22,"halted":0,"volume":171741,"hourTrading":{"tag":"盘后","latestPrice":9.41,"preClose":9.49,"latestTime":"16:05 EDT","volume":203,"amount":1910.47,"timestamp":1743797110154},"delay":0,"floatShares":0,"shares":19279000,"eps":0,"marketStatus":"Market Closed","change":-0.73,"latestTime":"04-04 16:00:00 EDT","open":10.11,"high":10.11,"low":9.45,"amount":1676064.9539,"amplitude":0.064579,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":10.22,"aum":0,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":9.41,"preClose":9.49,"latestTime":"16:05 EDT","volume":203,"amount":1910.47,"timestamp":1743797110154},"volumeRatio":2.372290204666303},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.372290204666303,"shares":19279000,"dividePrice":1.2,"high":10.11,"amplitude":0.064579,"preClose":10.22,"low":9.45,"week52Low":9.45,"pbRate":"--","week52High":11.766,"institutionHeld":0,"latestPrice":9.49,"eps":0,"divideRate":0.126449,"volume":171741,"delay":0,"ttmEps":0,"open":10.11,"prevYearClose":10.15,"prevWeekClose":10.55,"prevMonthClose":10.58,"prevQuarterClose":10.58,"fiveDayClose":10.55,"twentyDayClose":10.4956,"sixtyDayClose":10.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2479920037","title":"Data Vault Holdings, Inc.® Receives Foundational Web 3.0 Data, Blockchain and Artificial Intelligence Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2479920037","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479920037?lang=en_us&edition=fundamental","pubTime":"2024-10-30 20:35","pubTimestamp":1730291700,"startTime":"0","endTime":"0","summary":"The Datavault Intellectual Property Portfolio Adds Coveted Blockchain Utilities and Patented DataValue and DataScore Supercomputer Software Applications. These Datavault Patents Comprise Part of the Asset Purchase by WiSA Technologies, Inc.NEW YORK, October 30, 2024----Data Vault Holdings, Inc., a private company leading the way in data visualization, valuation, and monetization, which has entered into a definitive asset purchase agreement to sell its Datavault and ADIO IP and IT assets to WiSA Technologies, Inc.  , a leading provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems, today announced its Datavault operation has received three new patents and one new allowance from the United States Patent Office and related International Publication of its now patented innovations.These are Datavault’s second and third patents received cover blockchain and secure token driven data scoring, valuation, visualization and monetiz","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/m_uUggcT_CTuWJE61SuHjw--~B/aD0yNjE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8f30994ce66378bcdbb002eec2dfe762","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/m_uUggcT_CTuWJE61SuHjw--~B/aD0yNjE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8f30994ce66378bcdbb002eec2dfe762"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/data-vault-holdings-inc-receives-123500608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WISA","BK4141","BCI","IDE"],"gpt_icon":0},{"id":"2478699820","title":"A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2478699820","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478699820?lang=en_us&edition=fundamental","pubTime":"2024-10-25 04:33","pubTimestamp":1729801980,"startTime":"0","endTime":"0","summary":"First-of-its-kind, all-in-one HD-mapping and dual energy  ablation catheter. Now with two pulsed field ablation  offerings and a portfolio of electrophysiology solutions, Medtronic is shaping the future of arrythmia treatment today. GALWAY, Ireland, Oct. 24, 2024 /PRNewswire/ --Medtronic plc , a global leader in healthcare technology, today announced United States Food and Drug Administration  approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density  mapping and pulsed field  and radiofrequency  ablation catheter for treatment of persistent atrial fibrillation  and for RF ablation of cavotricuspid isthmus  dependent atrial flutter.With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation  while the Affera Sphere-9 c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/C6W0yp..bJuY5TXP5qpwJA--~B/aD00MDA7dz0yMzQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fc061aae331d3f70c7a1ebb47b1ed785","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/C6W0yp..bJuY5TXP5qpwJA--~B/aD00MDA7dz0yMzQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fc061aae331d3f70c7a1ebb47b1ed785"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/paradigm-electrophysiology-medtronic-receives-fda-203300768.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/paradigm-electrophysiology-medtronic-receives-fda-203300768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211331839.USD","LU0868494708.USD","IE00BSNM7G36.USD","LU2089284900.SGD","LU1162221912.USD","LU0868494617.USD","LU0211326755.USD","LU1989764748.USD","LU1989772923.USD","BK4588","MDT","LU1291159041.SGD","IE00BQXX3F31.USD","LU0943347566.SGD","LU0976567544.SGD","LU0820562030.AUD","BK4566","LU0072461881.USD","LU2089283258.USD","LU0234572021.USD","LU0354030511.USD","IE00BKVL7J92.USD","LU0208291251.USD","LU0320765489.SGD","LU1551013342.USD","LU2756315318.SGD","LU1496350171.SGD","LU1989764664.SGD","BK4083","BK4585","LU2111349929.HKD","LU1496350502.SGD","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU1551013425.SGD","LU2756315664.SGD","PVI","VT","LU1914381329.SGD","BK4550","HD","IDE","LU1093756325.SGD","LU1989771016.USD","RF","BK4533","IE00B3T34201.USD","BK4082","LU2271345857.HKD"],"gpt_icon":0},{"id":"2477682099","title":"Data Vault Holdings Unveils DVHolo: A Next-Generation Hologram Product Suite Powered by ADIO® in Partnership with HYPERVSN","url":"https://stock-news.laohu8.com/highlight/detail?id=2477682099","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477682099?lang=en_us&edition=fundamental","pubTime":"2024-10-24 20:05","pubTimestamp":1729771500,"startTime":"0","endTime":"0","summary":"Innovative technology backed by industry leaders, including Sir Richard Branson, set to transform digital experiences across advertising, signage, and live events. Global holographic display market is expected to reach over $23 billion by 2032. NEW YORK, October 24, 2024----Data Vault Holdings, Inc., a private company leading the way in data visualization, valuation, and monetization, which has entered into a definitive asset purchase agreement to sell its Datavault and ADIO IP and IT assets to WiSA Technologies, Inc. , a leading provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems, today announces its launch of DVHolo, its hologram product suite, powered by ADIO and developed in partnership with HYPERVSN, renowned for its innovative holographic solutions and backed by prominent venture investors, including Sir Richard Branson and Mark Cuban. DVHolo is a step forward in the fields of advertising, signage and live events","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4ekydTj3OxwlYD2psymTAA--~B/aD0yNjE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ec0089cc880360382cbb1418194ea82e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4ekydTj3OxwlYD2psymTAA--~B/aD0yNjE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ec0089cc880360382cbb1418194ea82e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/data-vault-holdings-unveils-dvholo-120500034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WISA","IDE","BK4141"],"gpt_icon":0},{"id":"2477785533","title":"Press Release: WiSA Technologies Announces Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2477785533","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477785533?lang=en_us&edition=fundamental","pubTime":"2024-10-21 19:10","pubTimestamp":1729509000,"startTime":"0","endTime":"0","summary":"WiSA Technologies, Inc.  in definitive agreement to acquire assets of Data Vault Holdings, Inc. to form a data technology & licensing company leveraging IP & proprietary HPC software, announces management will participate in investor events over the next several weeks as follows.Summary of WiSA Technologies & Datavault Business Combination. Presentation materials and any associated webcast links will also be posted on the Investor Relations portion of the company's website at WiSA Technologies.Data Vault Holdings Inc. is a technology holding company that provides a proprietary, cloud-based platform for the delivery of blockchain objects. Data Vault Holdings Inc. provides businesses with the tools to monetize data assets securely over its Information Data Exchange . The company is in the process of finalizing the consolidation of its affiliates Data Donate Technologies, Inc., ADIO LLC, and Datavault Inc. as wholly owned subsidiaries under one corporate structure. Learn more about Data V","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4141","BK4588","TQQQ","BABA","BK4555","QID","QLD","R","BK4585","WISA",".IXIC","TM","MNQmain","BK4099","NQmain","PSQ","BK4232","IDE","SQQQ","BK4022"],"gpt_icon":1},{"id":"2475369775","title":"Press Release: Voya Equity Closed End Funds Declare Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2475369775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475369775?lang=en_us&edition=fundamental","pubTime":"2024-10-16 05:45","pubTimestamp":1729028700,"startTime":"0","endTime":"0","summary":"Voya Investment Management, the asset management business of Voya Financial, Inc. , announced today the distributions on the common shares of five of its closed-end funds: Voya Global Advantage and Premium Opportunity Fund , Voya Global Equity Dividend and Premium Opportunity Fund , Voya Infrastructure, Industrials and Materials Fund , Voya Asia Pacific High Dividend Equity Income Fund , and Voya Emerging Markets High Dividend Equity Fund .With respect to each Fund, the distribution will be paid on November 15, 2024, to shareholders of record on November 1, 2024. The ex-dividend date is November 1, 2024. The distribution per share for each Fund is as follows:. The following table sets forth an estimate of the sources of each Fund's October distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.Estimated Sources                             Fiscal YTD                    ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAV","IGA","IDE","BK4585","BK4232","IHD","BK4588","BK4022","BK4184","EQR","LU0211331839.USD","LU0061475181.USD","R","VOYA","BK4215","LU1878469433.USD","IGD","IAE"],"gpt_icon":0},{"id":"2475697128","title":"Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2475697128","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475697128?lang=en_us&edition=fundamental","pubTime":"2024-10-16 05:41","pubTimestamp":1729028460,"startTime":"0","endTime":"0","summary":"VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION. Voya Global Advantage and Premium Opportunity Fund  and Voya Infrastructure, Industrials and Materials Fund   today announced important information concerning the Funds' distributions declared in September 2024. This press release is issued as required by the Funds' Managed Distribution Plan  and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the October distribution. It is not determinative of the tax character of the Funds' distributions for the 2024 calendar year. Shareholders should note that the Funds' total regular distribution amo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","IDE","NAV","LU0061475181.USD","LU0211331839.USD","IGA","VOYA","FUND","BK4184","ARKG"],"gpt_icon":0},{"id":"2474724175","title":"FDA Grants iota Biosciences IDE Approval for First-In-Human Early Feasibility Study with Implantable Bladder Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2474724175","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474724175?lang=en_us&edition=fundamental","pubTime":"2024-10-11 01:00","pubTimestamp":1728579600,"startTime":"0","endTime":"0","summary":"ALAMEDA, Calif., Oct. 10, 2024 /PRNewswire/ --iota Biosciences, Inc., a wholly-owned subsidiary of Astellas Pharma Inc.  announced today that the U.S. Food and Drug Administration  has approved its Investigational Device Exemption  for an Early Feasibility Study . The EFS will evaluate the safety and feasibility of an investigational implantable device designed to deliver electrical stimulation directly to the bladder wall, inducing contractions that facilitate bladder emptying in individuals impacted by underactive bladder .About AstellasAstellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+ healthcare solutions that combine our expertise an","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YG3qycgoBeD1Ep4Cch49aQ--~B/aD0xMTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2ea847d4f0afcbab05cc0666e5cfd53b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YG3qycgoBeD1Ep4Cch49aQ--~B/aD0xMTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2ea847d4f0afcbab05cc0666e5cfd53b"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fda-grants-iota-biosciences-ide-170000863.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-grants-iota-biosciences-ide-170000863.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ALPMF","ALPMY","IDE"],"gpt_icon":0},{"id":"2474740991","title":"InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent","url":"https://stock-news.laohu8.com/highlight/detail?id=2474740991","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474740991?lang=en_us&edition=fundamental","pubTime":"2024-10-10 21:45","pubTimestamp":1728567900,"startTime":"0","endTime":"0","summary":"InspireMD’s NSPR recently announced that the FDA has granted investigational device exemption  or premarket approval for its CGuard Prime 80cm carotid stent system. This approval allows the company to market its carotid stent system in the U.S. market for treating carotid artery stenosis , a condition that increases the risk of stroke.The approval is based on the impressive clinical trial results of the CGuard stent system, which demonstrated strong efficacy and safety in preventing stroke during carotid revascularization procedures.Before receiving premarket approval from the FDA, InspireMD's CGuard system had already obtained a CE mark in 2024. The system uses InspireMD's proprietary MicroNet technology, which is designed to trap embolic debris while maintaining uninterrupted blood flow. This technology provides a long-term, stroke-free solution for patients with carotid artery disease. The device's clinical success in Europe laid the foundation for InspireMD's FDA submission, aiming","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vZlajmbYZzKfSC9h66RaJg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vZlajmbYZzKfSC9h66RaJg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspiremd-gains-fda-premarket-approval-134500228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0009355771.USD","BSX","LU1989764748.USD","IDE","LU0011850046.USD","LU0267386448.USD","IE00BJJMRZ35.SGD","BK4504","LU0320765489.SGD","LU0882574055.USD","GEHC","LU1718418525.SGD","LU2491050071.SGD","IE0002141913.USD","LU1291159041.SGD","NSPR","LU2491049909.HKD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU0158827781.USD","LU0208291251.USD","LU2111349929.HKD","LU0823417653.USD","BK4588","LU0211331839.USD","LU1061106388.HKD","LU2112291526.USD","LU2491050154.USD","MDT","IE00B2B36J28.USD","LU1571399168.USD","LU2324357040.USD","LU2271345857.HKD","LU0345769631.USD","LU0077335932.USD","CAS","BK4585","LU0187121727.USD","LU1057294990.SGD","BK4533","LU0114720955.EUR","LU0070302665.USD","LU0122379950.USD","LU0353189763.USD","LU0976567544.SGD","LU0950375773.USD","LU0211326755.USD","LU0124676726.USD","LU2362541513.USD"],"gpt_icon":0},{"id":"2474528917","title":"Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2474528917","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474528917?lang=en_us&edition=fundamental","pubTime":"2024-10-09 04:54","pubTimestamp":1728420840,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., Oct. 8, 2024 /PRNewswire/ -- Talphera, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit and will be available for 1x1 meetings with registered investors. The summit is being held on October 15-17, 2024.About Talphera, Inc.Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption  as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration .This release is intended for investors only. For additional","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sQPWhDWk5SmY5Z6YVE9dzg--~B/aD02OTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/0c55efac9705092c41bfeaacb985f609","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sQPWhDWk5SmY5Z6YVE9dzg--~B/aD02OTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/0c55efac9705092c41bfeaacb985f609"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/talphera-participate-fireside-chat-2024-205400053.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/talphera-participate-fireside-chat-2024-205400053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SMMF","BK4007","BK4137","BK4211","HCSG","TLPH","IDE"],"gpt_icon":0},{"id":"2473293054","title":"Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2473293054","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473293054?lang=en_us&edition=fundamental","pubTime":"2024-10-08 20:01","pubTimestamp":1728388860,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced thatJames Frakes, Chief Executive Officer and Chief Financial Officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit, hosted by Anthony Vendetti, executive managing director and head of research at Maxim Group, on Tuesday, October 15, 2024 at 4:30 pm ET.To listen to the company presentation, sign up for the conference using this link.Company Contact:Jim FrakesChief Executive Officer and Chief Financial OfficerAethlon Medical, Inc.Jfrakes@aethlonmedical.com","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/2CFWCtWFteGFgmre49Hqxw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/d2794e091e15f865403603a3feabb73e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/2CFWCtWFteGFgmre49Hqxw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/d2794e091e15f865403603a3feabb73e"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aethlon-medical-participate-2024-maxim-120100463.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aethlon-medical-participate-2024-maxim-120100463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","SMMF","BK4568","BK4137","IDE","BK4082","AEMD","BK4211","HCSG"],"gpt_icon":0},{"id":"2473433145","title":"PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2473433145","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473433145?lang=en_us&edition=fundamental","pubTime":"2024-10-08 04:04","pubTimestamp":1728331440,"startTime":"0","endTime":"0","summary":"A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate Cancer Represents Potential Paradigm Shift in Ho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/07/2959294/0/en/PROCEPT-BioRobotics-Received-U-S-FDA-Approval-to-Initiate-Pivotal-Randomized-Clinical-Study-for-Prostate-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2324357040.USD","PRCT","IDE"],"gpt_icon":0},{"id":"2473310176","title":"BRIEF-InspireMD Announces Approval Of Application For Pivotal Study Of The CGuard Prime 80Cm Carotid Stent System","url":"https://stock-news.laohu8.com/highlight/detail?id=2473310176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473310176?lang=en_us&edition=fundamental","pubTime":"2024-10-07 19:03","pubTimestamp":1728299031,"startTime":"0","endTime":"0","summary":"Oct 7 (Reuters) - InspireMD Inc   :   * INSPIREMD ANNOUNCES APPROVAL OF INVESTIGATIONAL DEVICE EXEMPTION (IDE) APPLICATION FOR CGUARDIANS II PIVOTAL STUDY OF THE CGUARD PRIME 80CM CAROTID STENT SYSTEMSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSPR","BK4198","IDE"],"gpt_icon":0},{"id":"2473354176","title":"InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System","url":"https://stock-news.laohu8.com/highlight/detail?id=2473354176","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473354176?lang=en_us&edition=fundamental","pubTime":"2024-10-07 19:00","pubTimestamp":1728298800,"startTime":"0","endTime":"0","summary":"MIAMI, Oct.  07, 2024  (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that the U.S. Foo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/07/2958796/0/en/InspireMD-Announces-Approval-of-Investigational-Device-Exemption-IDE-Application-for-CGUARDIANS-II-Pivotal-Study-of-the-CGuard-Prime-80cm-Carotid-Stent-System.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDE","BK4198","NSPR"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":93}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDE\",params:#limit:5,,,undefined,":[{"date":"2025-04-01","symbol":"IDE","amount":0.1,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-15","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-15"},{"date":"2025-03-03","symbol":"IDE","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-17","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-17"},{"date":"2025-02-03","symbol":"IDE","amount":0.1,"announcedDate":"2025-01-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-03","defaultRemindTime":1738593000000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-18","payableDate":"2025-02-03","currency":"USD","dateTimestamp":1738558800000,"payDate":"2025-02-18"},{"date":"2024-12-30","symbol":"IDE","amount":0.1,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-15","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-15"},{"date":"2024-12-02","symbol":"IDE","amount":0.1,"announcedDate":"2024-11-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-02","defaultRemindTime":1733149800000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-16","payableDate":"2024-12-02","currency":"USD","dateTimestamp":1733115600000,"payDate":"2024-12-16"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDE\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-07-15","value":0.405,"currency":"USD"},{"executeDate":"2015-10-01","recordDate":"2015-10-05","paymentDate":"2015-10-15","value":0.365,"currency":"USD"},{"executeDate":"2015-12-29","recordDate":"2015-12-31","paymentDate":"2016-01-15","value":0.365,"currency":"USD"},{"executeDate":"2016-04-01","recordDate":"2016-04-05","paymentDate":"2016-04-15","value":0.365,"currency":"USD"},{"executeDate":"2016-07-01","recordDate":"2016-07-06","paymentDate":"2016-07-15","value":0.365,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDE\",market:\"US\",delay:false,,,undefined,":{}}}